Impact of a hormone-releasing intrauterine system on the vaginal microbiome: a prospective baboon model

J Med Primatol. 2014 Apr;43(2):89-99. doi: 10.1111/jmp.12090. Epub 2013 Nov 23.

Abstract

Background: Use of a levonorgestrel-releasing intrauterine system (LNG-IUS) in humans may alter vaginal microbial populations and susceptibility to pathogens. This study evaluated the time-dependent effects of an LNG-IUS on the vaginal microbiome of the baboon, a useful animal model for reproductive studies.

Methods: Levonorgestrel-releasing intrauterine systems were inserted into three reproductively mature, female baboons. The animals were evaluated for 6 months by physical examination and Gram-stained cytology. The vaginal microbiota was characterized at each timepoint by culture-independent analysis of the 16S rRNA-encoding gene.

Results: Each baboon harbored a diverse vaginal microbiome. Interindividual variation exceeded intra-individual variation. Diversity declined over time in one baboon and showed mild fluctuations in the other two. There were no significant community differences from early to late post-LNG-IUS placement.

Conclusions: The baboon vaginal microbiome is unique to each individual and is polymicrobial. In this pilot study, the vaginal microbiome remained stable from early to late post-LNG-IUS placement.

Keywords: levonorgestrel; non-human primate; pyrosequencing.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Contraceptive Agents, Female / administration & dosage
  • Contraceptive Agents, Female / pharmacology*
  • Female
  • Intrauterine Devices, Medicated*
  • Levonorgestrel / administration & dosage
  • Levonorgestrel / pharmacology*
  • Microbiota / drug effects*
  • Models, Animal
  • Molecular Sequence Data
  • Papio anubis / microbiology*
  • Polymerase Chain Reaction
  • Prospective Studies
  • RNA, Ribosomal, 16S / genetics
  • RNA, Ribosomal, 16S / metabolism
  • Sequence Analysis, DNA
  • Ultrasonography
  • Uterus / diagnostic imaging
  • Vagina / drug effects*
  • Vagina / microbiology*

Substances

  • Contraceptive Agents, Female
  • RNA, Ribosomal, 16S
  • Levonorgestrel